Streamlining Gastroenterology Prior Authorizations After Olive AI Replacement

For gastroenterology practices navigating the landscape post-Olive AI replacement, Klivira offers a robust, EMR-integrated platform designed to automate and optimize prior authorization workflows specific to GI. Our solution ensures continuity and efficiency where previous systems left gaps.

Revenue cycle directors and prior authorization coordinators in gastroenterology face unique challenges, from high-volume biologic renewals to complex procedure authorizations. The discontinuation of platforms like Olive AI necessitates a strategic migration to a proven solution that understands these specialty-specific demands. Klivira provides that critical operational continuity and enhancement.

The Specifics of Gastroenterology Prior Authorization Burden

Gastroenterology prior authorizations are characterized by high-volume, clinically complex requirements across several categories. These include ongoing authorizations for biologics like Humira, Stelara, Skyrizi, and Entyvio for Crohn's and ulcerative colitis, as well as procedures such as colonoscopies, EGDs, and advanced imaging. The chronic nature of many GI conditions, particularly IBD, means a continuous cycle of re-authorizations and detailed documentation.

Key Prior Authorization Triggers in Gastroenterology

PA requirements in GI frequently arise from high-cost specialty drugs, advanced diagnostic procedures, and specific therapeutic interventions. Common triggers include IBD biologics (TNF inhibitors, integrin inhibitors, IL-12/23 inhibitors, JAK inhibitors, S1P modulators), Hepatitis C direct-acting antivirals, advanced imaging (MRCP, MR enterography, CT enterography), and endoscopic procedures like capsule endoscopy or ERCP. Bariatric surgery also often carries significant PA requirements.

Common Gastroenterology PA Denial Reasons

Step therapy non-compliance for IBD biologics (e.g., conventional therapy or biosimilar trial required).
Insufficient documentation of disease severity (e.g., missing Mayo score, CDAI).
Gaps in pre-treatment screening documentation (e.g., TB, hepatitis screening).
Inappropriate-use criteria for advanced imaging without sufficient clinical correlation.
Fibrosis stage or genotype documentation gaps for Hepatitis C DAAs.
Capsule endoscopy denial due to insufficient prior workup or non-compliant indication.

Klivira's Approach to Gastroenterology Prior Authorization Automation

Klivira's platform is engineered to navigate the intricate PA landscape of gastroenterology. We integrate with leading EMRs to automate data extraction, apply ACG and AGA guideline-aware step therapy logic for IBD biologics, and manage periodic re-authorization workflows. Our system accounts for treatment-naive vs. treatment-experienced classifications and handles the medical-vs-pharmacy benefit split common with biologic agents, ensuring accurate routing and submission.

Seamless Migration: Your Olive AI Replacement for GI

For organizations seeking an effective Olive AI replacement, Klivira offers a proven migration path that minimizes disruption to your gastroenterology operations. Our platform provides comprehensive connectivity to payer portals and utilizes X12 278, ePA, and NCPDP SCRIPT standards to submit authorizations efficiently. We ensure your practice maintains continuous, high-performance prior authorization processing, leveraging intelligent automation to reduce manual effort and improve turnaround times.

EMR and Payer Touchpoints for GI Prior Authorizations

EMR order types for biologics, advanced imaging, and endoscopic procedures.
Clinical templates for IBD disease activity scores (Mayo, CDAI) and Hep C fibrosis staging.
Payer portals for major commercial, Medicare, and Medicaid plans covering GI services.
Electronic prior authorization (ePA) channels for pharmacy benefit drugs.
Integration with specialty pharmacy networks for drug fulfillment and support.
Automated retrieval of payer policy libraries to ensure compliance with medical necessity criteria.

Frequently asked questions

How does Klivira handle the high volume of biologic re-authorizations in gastroenterology?

Klivira automates the periodic re-authorization workflow for chronic treatments like IBD biologics. Our system tracks authorization expiry dates, proactively initiates renewal requests, and leverages EMR data to populate necessary clinical documentation, significantly reducing the manual burden on your team.

Can Klivira integrate with our existing EMR for gastroenterology workflows?

Yes, Klivira is designed for deep integration with various EMR systems, including those commonly used in gastroenterology practices. We utilize secure, standardized protocols like SMART on FHIR to extract relevant clinical data, ensuring a seamless flow of information for prior authorization submissions.

How does Klivira address the medical vs. pharmacy benefit split for GI biologics?

Our platform intelligently identifies whether a biologic is administered under the medical or pharmacy benefit based on the order and patient's plan. It then routes the prior authorization request through the appropriate channel, whether it's an X12 278 transaction for medical benefit or an ePA/NCPDP SCRIPT submission for pharmacy benefit, ensuring correct processing.

What specific GI clinical guidelines does Klivira's logic incorporate?

Klivira's automation logic is informed by major gastroenterology clinical guidelines from bodies such as the ACG (American College of Gastroenterology), AGA (American Gastroenterological Association), and AASLD (American Association for the Study of Liver Diseases). This ensures that our system aligns with evidence-based criteria for conditions like IBD and Hepatitis C.

What is the migration process like for organizations moving from Olive AI to Klivira?

Our team works closely with your IT and revenue cycle departments to ensure a smooth transition. The migration involves integrating with your EMR, configuring GI-specific workflows, and training your staff. Our goal is to minimize disruption and quickly bring your gastroenterology prior authorization processes to full operational efficiency on the Klivira platform.